Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route

来源 :药学学报(英文版) | 被引量 : 0次 | 上传用户:xwy_pk
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Self-microemulsifying drug delivery systems(SMEDDSs)have recently returned to the lime-light of academia and industry due to their enormous potential in oral delivery of biomacromolecules.However,information on gastrointestinal lipolysis and trans-epithelial transport of SMEDDS is rare.Aggregation-caused quenching(ACQ)fluorescent probes are utilized to visualize the in vivo behaviors of SMEDDSs,because the released probes during lipolysis are quenched upon contacting water.Two SMEDDSs composed of medium chain triglyceride and different ratios of Tween-80 and PEG-400 are set as models,meanwhile Neoral? was used as a control.The SMEDDS droplets reside in the digestive tract for as long as 24 h and obey first order kinetic law of lipolysis.The increased chain length of the triglyceride decreases the lipolysis of the SMEDDSs.Ex vivo imaging of main tissues and histological examination confirm the trans-epithelial transportation of the SMEDDS droplets.Approximately 2%-4%of the given SMEDDSs are transported via the lymph route following epithelial uptake,while liver is the main termination.Caco-2 cell lines confirm the cellular uptake and trans-epithelial transport.In conclusion,a fraction of SMEDDSs can survive the lipolysis in the gastrointestinal tract,permeate across the epithelia,translocate via the lymph,and accumulate mainly in the liver.
其他文献
The initiation and development of major inflammatory diseases,i.e.,cancer,vascular inflam-mation,and some autoimmune diseases are closely linked to the immune system.Biologics-based immu-notherapy is exerting a critical role against these diseases,whereas
Heart failure(HF)is a global public health problem with high morbidity and mortality.A large number of studies have shown that HF is caused by severe energy metabolism disorders,which result in an insufficient heart energy supply.This deficiency causes ca
When nanoparticles were introduced into the biological media,the protein corona would be formed,which endowed the nanoparticles with new bio-identities.Thus,controlling protein corona for-mation is critical to in vivo therapeutic effect.Controlling the pa
As one of the most important components of caveolae,caveolin-1 is involved in caveolae-mediated endocytosis and transcytosis pathways,and also plays a role in regulating the cell membrane cholesterol homeostasis and mediating signal transduction.In recent
Ten years ago,in 2011,we founded Acta Pharmaceutica Sinica B(APSB) with the goal of creating a global high-level forum centered around drug discovery and pharmaceutical research/application.Our first priority was and will always be to serve our readers an
期刊
Current advances of immunotherapy have greatly changed the way of cancer treatment.At the same time,a great number of nanoparticle-based cancer immunotherapies(NBCIs)have also been explored to elicit potent immune responses against tumors.However,few NBCI
CD8+ T lymphocytes are pivotal cells in the host response to antitumor immunity.Tumor-driven microenvironments provide the conditions necessary for regulating infiltrating CD8+ T cells in favor of tumor survival,including weakening CD8+ T cell activation,
The beneficial or deleterious effects of nanomedicines emerge from their complex interac-tions with intracellular pathways and their subcellular fate.Moreover,the dynamic nature of plasma membrane accounts for the movement of these nanocarriers within the
The intracellular retention of nanotherapeutics is essential for their therapeutic activity.The immobilization of nanotherapeutics inside target cell types can regulate various cell behaviors.However,strategies for the intracellular immobilization of nano
Nanocrystal formulations have been explored to deliver poorly water-soluble drug molecules.Despite various studies of nanocrystal formulation and delivery,much more understanding needs to be gained into absorption mechanisms and kinetics of drug nanocryst